Exact Therapeutics AS

Exact Therapeutics AS Net Debt

The Net Debt of Exact Therapeutics AS (EXTX.OL) as of Oct 18, 2026 is -99.48 M NOK. In the previous year, Net Debt was -45.78 M NOK — a change of 117.30% (lower).

Net Debt

-99.48 MNOK

YoY

117.30%

Last updated:

Net Debt of Exact Therapeutics AS is 2024 -99.48 M NOK. Net Debt of Exact Therapeutics AS was 2023 -45.78 M NOK. It decreases by 117.30% lower compared to the previous year.

The Exact Therapeutics AS Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2017
-15.15 M NOK
Jan 1, 2018
-58.67 M NOK
Jan 1, 2019
-45.00 M NOK
Jan 1, 2020
-159.42 M NOK
Jan 1, 2021
-102.33 M NOK
Jan 1, 2022
-68.20 M NOK
Jan 1, 2023
-45.78 M NOK
Jan 1, 2024
-99.48 M NOK
The Exact Therapeutics AS Net Debt history
YEARNet DebtYoY
-99.48 MNOK+117.30%
-45.78 MNOK-32.87%
-68.20 MNOK-33.36%
-102.33 MNOK-35.81%
-159.42 MNOK+254.29%
-45.00 MNOK-23.30%
-58.67 MNOK+287.26%
-15.15 MNOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Exact Therapeutics AS Stock analysis

What does Exact Therapeutics AS do? Exact Therapeutics AS is a clinical stage biopharmaceutical company headquartered in Oslo, Norway, specializing in biotechnology within the Health Care sector. The company focuses on developing a novel platform for ultrasound-mediated therapeutic amplification, specifically targeting drug enhancement through ACT sonoporation. This technology aims to amplify the clinical utility of various therapeutic agents across cancer, infectious diseases, and neurological conditions. Listed on 14 July 2020, Exact Therapeutics operates with a team of eight employees. Exact Therapeutics AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Exact Therapeutics AS stock

Net Debt of Exact Therapeutics AS is -99.48 M NOK in 2024.

Net Debt of Exact Therapeutics AS changed from -45.78 M NOK to -99.48 M NOK, representing a 117.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Exact Therapeutics AS since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Exact Therapeutics AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Exact Therapeutics AS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Exact Therapeutics AS